Legend Biotech Corp (LEGN) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$1.0B

Net Income/Loss (FY2025)

-$296.8M

Total Assets (FY2025)

$1.7B

Total Equity (FY2025)

$1.0B

Cash Flows from Operating Activities (FY2025)

-$100.2M

Source: Legend Biotech Corp 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.